Evidence map›Paper›PMID 37576794›Full record

ArticleBalkan journal of medical genetics : BJMG2023

Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?

N Aladağ, H Ali Barman, A Şipal, T Akbulut, M Özdemir, S Ceylaner

Open access · goldAbstract read
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

N AladağVan Yüzüncü yıl University, Faculty of Medicine, Department of Cardiology, Van, Turkey.
H Ali BarmanIstanbul University - Cerrahpaşa, Institute of Cardiology, Department of Cardiology, Istanbul, Turkey.
A ŞipalUniversity of Health Sciences, Van Training and Research Hospital, Department of Cardiology, Van, Turkey.
T AkbulutUniversity of Health Sciences, Van Training and Research Hospital, Department of Cardiology, Van, Turkey.
M ÖzdemirBayrampaşa Kolan Hospital, Department of Cardiology, İstanbul, Turkey.
S CeylanerIntergen Genetic Centre, Department of Medical Genetics, Ankara, Turkey.
Sağlık Bilimleri Üniversitesi · TRIntergen (Turkey) · TRIstanbul University-Cerrahpaşa · TRVan Yüzüncü Yıl Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fabry disease (FD) is an X-linked, lysosomal glycosphingolipid storage disorder that occurs very rarely. Cardiac involvement may comprise of left ventricular hypertrophy (LVH), arrhythmias, conduction abnormalities, heart failure and valvular abnormalities. The goal of this study was to conduct gene analysis for FD in patients suffering from unexplained LVH. 120 patients over the age of 30 who were diagnosed by echocardiography with idiopathic LVH were included in the study. Patients with severe hypertension, intermediate valve disease such as moderate aortic stenosis, known FD, and a family history of autosomal dominant hypertrophic cardiomyopathy were excluded from the study.

Indexed as

Fabry DiseaseGLA mutationpolymorphismUnexplained left ventricular hypertrophy

Identifiers

PMID37576794
PMCPMC10413883
OpenAlexW4385730145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.